Nutriband Inc. (NASDAQ: NTRB), a company focused on developing transdermal pharmaceutical products, announced that Chairman Serguei Melnik will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference on Wednesday, Oct. 8, 2025, at 3 p.m. ET. The presentation will include a fireside Q&A session with questions from the live virtual audience, and registered investors can also schedule one-on-one meetings with Melnik. Interested attendees can register at no cost via the conference's official site. A video webcast of the presentation will be available on Channelchek, Noble's investor portal, and archived for 90 days on both Channelchek.com and Nutriband's website.
This announcement is significant because it provides Nutriband with a platform to present its lead product, an abuse-deterrent fentanyl patch incorporating the company's AVERSA™ technology. The AVERSA™ technology is designed to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. Given the ongoing opioid crisis, a technology that can deter abuse of potent opioids like fentanyl is of critical importance. Nutriband's participation in this conference could attract potential investors and partners interested in addressing this public health issue.
For more details on the presentation, the full press release can be accessed at https://ibn.fm/MQAEm. Nutriband's website is www.nutriband.com, and the latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB.
Nutriband is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Its lead product under development is an abuse-deterrent fentanyl patch incorporating the AVERSA™ abuse-deterrent technology. The company's focus on transdermal delivery and abuse deterrence places it at the intersection of pharmaceutical innovation and public health needs. The conference presentation will likely highlight the potential of AVERSA™ technology to be incorporated into any transdermal patch, offering a broad application for drugs with abuse potential.
The Emerging Growth Virtual Equity Conference by Noble Capital Markets is known for featuring companies with innovative technologies and growth potential. Nutriband's selection to present indicates recognition of its potential in the biotech sector. The fireside Q&A format allows for direct engagement with investors, which could enhance understanding of the technology and its market opportunity.
In summary, Nutriband's upcoming presentation at this conference is important as it provides a venue to showcase a technology that could help mitigate opioid abuse, a pressing societal issue. The company's ability to communicate its value proposition to investors and stakeholders could be pivotal for its growth and the broader adoption of abuse-deterrent technologies.
